{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:29:49Z","timestamp":1761560989186},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s10620-005-2787-2","type":"journal-article","created":{"date-parts":[[2005,7,19]],"date-time":"2005-07-19T16:16:10Z","timestamp":1121789770000},"page":"1356-1360","source":"Crossref","is-referenced-by-count":16,"title":["Chronic Albumin Infusions to Achieve Diuresis in Patients with Ascites Who Are Not Candidates for Transjugular Intrahepatic Portosystemic Shunt (TIPS)"],"prefix":"10.1007","volume":"50","author":[{"given":"J.","family":"Trotter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pieramici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. T.","family":"Everson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"2787_CR1","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","volume":"350","author":"P Gines","year":"2004","unstructured":"Gines P, Cardenas A, Arroyo V, Rodes J: Management of cirrhosis and ascites. N Engl J Med 350:1646\u20131654, 2004","journal-title":"N Engl J Med"},{"key":"2787_CR2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","volume":"38","author":"KP Moore","year":"2003","unstructured":"Moore KP, Wong F, Gines P, et al.: The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 38:258\u2013266, 2003","journal-title":"Hepatology."},{"key":"2787_CR3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1172\/JCI101514","volume":"23","author":"CA Janeway","year":"1944","unstructured":"Janeway CA, Gibson ST, Woodruff LM, Heyl JT, Bailey GT, Newhouser LR:. Chemical, clinical and immunological studies on the products of human plasma fractionation: concentrated human serum albumin. J Clin Invest 23:465\u2013491, 1944","journal-title":"J Clin Invest"},{"key":"2787_CR4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1172\/JCI102108","volume":"28","author":"WN Faloon","year":"1949","unstructured":"Faloon WN, Echkardt RD, Murphy TL, Cooper AM, Davidson CS: An evaluation of human serum albumin in the treatment of cirrhosis of the liver. J Clin Invest 28:583\u2013594, 1949","journal-title":"J Clin Invest"},{"key":"2787_CR5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0016-5085(19)36570-9","volume":"16","author":"WP Havens","year":"1950","unstructured":"Havens WP, Bluemle LW: The effect of human serum albumin and mercurial diuretics on ascites in patients with hepatic cirrhosis. Gastroenterology 16:455\u2013474, 1950","journal-title":"Gastroenterology"},{"key":"2787_CR6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1172\/JCI101916","volume":"27","author":"AJ Patek","year":"1948","unstructured":"Patek AJ, Mankin H, Colcher H, Lowell A, Earle DP: The effects of intravenous infection of concentrated human serum albumin upon blood plasma, ascites and renal function in three patients with cirrhosis of the liver. J Clin Invest 27:135\u2013145, 1948","journal-title":"J Clin Invest"},{"key":"2787_CR7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1172\/JCI101959","volume":"27","author":"HG Kunkel","year":"1948","unstructured":"Kunkel HG, Labby DH, Ahrens EH, Shank RE, Hoagland CL: The use of concentrated human serum albumin in the treatment of cirrhosis of the liver. J Clin Invest 27:305\u2013320, 1948","journal-title":"J Clin Invest"},{"key":"2787_CR8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00000441-194906000-00009","volume":"217","author":"CJ Watson","year":"1949","unstructured":"Watson CJ, Greenberg A: Certain effects of salt poor human albumin in cases of hepatic disease. Am J Med Sci 217:651\u2013657, 1949","journal-title":"Am J Med Sci"},{"key":"2787_CR9","first-page":"297","volume":"30","author":"PW Dykes","year":"1961","unstructured":"Dykes PW: A study of the effects of albumin infusions in patients with cirrhosis of the liver. Q J Med 30:297\u2013327, 1961","journal-title":"Q J Med"},{"key":"2787_CR10","first-page":"304","volume":"25","author":"GW Thorn","year":"1946","unstructured":"Thorn GW, Armstrong SH, Davenport VD: Chemical, clinical, and immunological studies on the products of human plasma fractionation. XXXI. The use of salt\u2013poor concentrated human serum albumin solution in the treatment of hepatic cirrhosis. J Clin Invest 25:304\u2013323, 1946","journal-title":"XXXI. The use of salt\u2013poor concentrated human serum albumin solution in the treatment of hepatic cirrhosis. J Clin Invest"},{"key":"2787_CR11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archinte.1951.03810060002001","volume":"87","author":"J Post","year":"1954","unstructured":"Post J, Rose JV, Shore SM: Intravenous use of salt-poor human albumin. Arch Intern Med 87:775\u2013788, 1954","journal-title":"Arch Intern Med"},{"key":"2787_CR12","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0168-8278(99)80329-8","volume":"31","author":"C Schindler","year":"1999","unstructured":"Schindler C, Ramadori G: Albumin substitution improves urinary sodium excretion and diuresis in patients with liver cirrhosis and refractory ascites. J Hepatol 31:1132, 1999","journal-title":"J Hepatol"},{"key":"2787_CR13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0168-8278(99)80194-9","volume":"30","author":"P Gentilini","year":"1999","unstructured":"Gentilini P, Casini-Raggi V, DiFiore GD, et al. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol 30:639\u2013645, 1999","journal-title":"J Hepatol"},{"key":"2787_CR14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0168-8278(99)80207-4","volume":"30","author":"L Blendis","year":"1999","unstructured":"Blendis L, Wong F: Intravenous albumin with diuretics: protean lesions to be learnt? J Hepatol 30:727\u2013730, 1999","journal-title":"J Hepatol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-2787-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-005-2787-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-2787-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T08:23:47Z","timestamp":1586334227000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-005-2787-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["2787"],"URL":"https:\/\/doi.org\/10.1007\/s10620-005-2787-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}